Glaukos (GKOS)
(Delayed Data from NYSE)
$112.72 USD
+2.02 (1.82%)
Updated May 31, 2024 04:00 PM ET
After-Market: $112.70 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Glaukos Corporation [GKOS]
Reports for Purchase
Showing records 81 - 100 ( 124 total )
Company: Glaukos Corporation
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Glaukos Corporation
Industry: Medical - Instruments
Company: Glaukos Corporation
Industry: Medical - Instruments
Company: Glaukos Corporation
Industry: Medical - Instruments
Company: Glaukos Corporation
Industry: Medical - Instruments
Company: Glaukos Corporation
Industry: Medical - Instruments
Company: Glaukos Corporation
Industry: Medical - Instruments
Company: Glaukos Corporation
Industry: Medical - Instruments
Healthcare - Coverage Update - Healthcare Sector
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
We are placing shares of GKOS Under Review, and transferring coverage to Scott Henry, CFA due to the departure of the covering analyst.
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Near-Term Transient Headwinds Linger, But Long-Term Thesis Unchanged
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
iStent Inject Standalone Study Publication Unveils Positive Results
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
ASCRS Reinforces MIGS Long-Term Opportunities; Buy
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Solid 2017 Start on 1Q Beat, 2017 Guidance Raise
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
Making Glaucoma Great Again - Management Travels Reaffirm Bullish Outlook
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.